glp-1 drugs retatrutide Retatrutide, a GIP, and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA The experimental GLP-1 drug 'reta'

You should speak with your doctor to determine the best time to take the medication

These medication-specific considerations highlight the importance of tailoring treatment plans for vulnerable CKD populations

"Obesity is a chronic disease and like other chronic diseases, it may require chronic medication," Siegel says

First, verify adequate dosing and duration

The combination of GLP-1 and strength training offers the best path to a leaner and stronger body composition

GLP-1 medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) deliver remarkable weight loss but create a critical nutritional challenge: maintaining adequate protein intake